Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

219
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
219
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

198
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
198
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

253
The pathophysiology of pneumonia involves the following steps:
253
Pneumonia IV: Management01:28

Pneumonia IV: Management

319
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
319
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

2.0K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.0K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Food is the Best Medicine (FBM): design and baseline findings from a multi-arm randomized controlled trial among food-insecure postpartum mothers in Texas.

BMC nutrition·2026
Same author

Structure-function relationships governing the multimodal antioxidant protection of quinoa protein hydrolysates.

Food chemistry·2026
Same author

[Neuropsychiatric Effects of Creatine: What Does the Preclinical and Clinical Evidence Conclude?]

Revista medica de Chile·2026
Same author

Implementation of the first adolescence-to-adulthood transition programme for Multiple Sclerosis in Latin America.

Multiple sclerosis and related disorders·2026
Same author

Delphi method validation of a tool for planning home visits in palliative care: palliative care parametrisation tool.

Ecancermedicalscience·2026
Same author

Real-life experience of teduglutide use in pediatric patients with short bowel syndrome in Argentina. A multicenter study.

Intestinal Failure (New York, N.Y.)·2026

Related Experiment Video

Updated: Jun 23, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.1K

[Mortality in bacterial pneumonia due to pneumococcus].

Diego Sousa Matias1, Mariano Fielli1, Alejandra González1

  • 1Servicio de Neumonología, Sección Bacteriología. Hospital Nacional Profesor Alejandro Posadas, El Palomar, Buenos Aires, Argentina.

Medicina
|June 22, 2024
PubMed
Summary

Pneumococcal bacteremic pneumonia has high mortality. Key mortality factors include altered mental status, bilateral lung compromise on X-ray, need for mechanical ventilation, and low oxygen levels, consistent with existing prognostic scores.

Keywords:
mortalitypneumococcuspneumoniaprognosis

More Related Videos

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa
07:27

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa

Published on: July 12, 2018

5.6K
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

14.7K

Related Experiment Videos

Last Updated: Jun 23, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.1K
Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa
07:27

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa

Published on: July 12, 2018

5.6K
A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

14.7K

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Critical Care Medicine

Context:

  • Pneumonia remains a significant cause of mortality globally.
  • Bacteremic pneumonia, particularly caused by Streptococcus pneumoniae, presents a severe clinical challenge.
  • Effective management requires understanding specific mortality predictors.

Purpose:

  • To identify clinical and radiological factors associated with mortality in adult patients with pneumococcal bacteremic pneumonia.
  • To compare these factors with established prognostic scores.

Summary:

  • A retrospective cohort study analyzed 152 adult patients with pneumococcal bacteremic pneumonia.
  • Mortality was 34%. Significant predictors included altered mental status, tachypnea, low PaO2/FiO2 ratio, bilateral radiographic findings, and need for mechanical ventilation.
  • Logistic regression identified mechanical ventilation, altered mental status, bilateral chest X-ray, and low PaO2/FiO2 ratio as independent mortality predictors.

Impact:

  • Findings reinforce the importance of recognized prognostic indicators in bacteremic pneumonia.
  • Highlights the need for prompt recognition and management of these critical factors to improve patient outcomes.
  • Supports the continued use of established prognostic scores in clinical practice for risk stratification.